106 related articles for article (PubMed ID: 15175044)
21. Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-gamma in vitro.
Saunders NA; Smith RJ; Jetten AM
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):147-52. PubMed ID: 8049075
[TBL] [Abstract][Full Text] [Related]
22. Affinity purification of an interferon-induced human guanylate-binding protein and its characterization.
Cheng YS; Becker-Manley MF; Chow TP; Horan DC
J Biol Chem; 1985 Dec; 260(29):15834-9. PubMed ID: 3934165
[TBL] [Abstract][Full Text] [Related]
23. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
24. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.
Zhang CL; Kamarashev J; Qin JZ; Burg G; Dummer R; Döbbeling U
J Pathol; 2003 Jun; 200(2):249-54. PubMed ID: 12754746
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases.
Britzen-Laurent N; Herrmann C; Naschberger E; Croner RS; Stürzl M
World J Gastroenterol; 2016 Jul; 22(28):6434-43. PubMed ID: 27605879
[TBL] [Abstract][Full Text] [Related]
26. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Fujita H; Ohmatsu H; Kakinuma T; Kadono T; Tamaki K; Sato S
J Invest Dermatol; 2010 Sep; 130(9):2304-11. PubMed ID: 20505746
[TBL] [Abstract][Full Text] [Related]
27. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
Goydos JS; Patel M; Shih W
J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121
[TBL] [Abstract][Full Text] [Related]
28. XAF1 expression is significantly reduced in human melanoma.
Ng KC; Campos EI; Martinka M; Li G
J Invest Dermatol; 2004 Dec; 123(6):1127-34. PubMed ID: 15610524
[TBL] [Abstract][Full Text] [Related]
29. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
30. Biochemical properties of the human guanylate binding protein 5 and a tumor-specific truncated splice variant.
Wehner M; Herrmann C
FEBS J; 2010 Apr; 277(7):1597-605. PubMed ID: 20180847
[TBL] [Abstract][Full Text] [Related]
31. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication.
Nordmann A; Wixler L; Boergeling Y; Wixler V; Ludwig S
FASEB J; 2012 Mar; 26(3):1290-300. PubMed ID: 22106366
[TBL] [Abstract][Full Text] [Related]
32. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
33. Lack of STAT 1 phosphorylation at TYR 701 by IFNgamma correlates with disease outcome in melanoma patients.
Boudny V; Dusek L; Adámková L; Chumchalová J; Kocak I; Fait V; Lauerová L; Krejcí E; Kovarík J
Neoplasma; 2005; 52(4):330-7. PubMed ID: 16059651
[TBL] [Abstract][Full Text] [Related]
34. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Reiss M; Karasavvas N; Zelenetz AD; Pugh W; Cabanillas F; Deisseroth AB; Duvic M
Clin Cancer Res; 1997 Feb; 3(2):169-77. PubMed ID: 9815669
[TBL] [Abstract][Full Text] [Related]
35. Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression.
Weinländer K; Naschberger E; Lehmann MH; Tripal P; Paster W; Stockinger H; Hohenadl C; Stürzl M
FASEB J; 2008 Dec; 22(12):4168-78. PubMed ID: 18697840
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected].
Hau P; Wise P; Bosserhoff AK; Blesch A; Jachimczak P; Tschertner I; Bogdahn U; Apfel R
J Invest Dermatol; 2002 Sep; 119(3):562-9. PubMed ID: 12230496
[TBL] [Abstract][Full Text] [Related]
37. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
38. The Large GTPase, GBP-2, Regulates Rho Family GTPases to Inhibit Migration and Invadosome Formation in Breast Cancer Cells.
Nyabuto GO; Wilson JP; Heilman SA; Kalb RC; Kopacz JP; Abnave AV; Vestal DJ
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830789
[TBL] [Abstract][Full Text] [Related]
39. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals.
Shenoy AR; Wellington DA; Kumar P; Kassa H; Booth CJ; Cresswell P; MacMicking JD
Science; 2012 Apr; 336(6080):481-5. PubMed ID: 22461501
[TBL] [Abstract][Full Text] [Related]
40. Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity.
Krapp C; Hotter D; Gawanbacht A; McLaren PJ; Kluge SF; Stürzel CM; Mack K; Reith E; Engelhart S; Ciuffi A; Hornung V; Sauter D; Telenti A; Kirchhoff F
Cell Host Microbe; 2016 Apr; 19(4):504-14. PubMed ID: 26996307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
